• Newsletters
  • Gift Membership
Logo Logo
Take Scroll With You Download the app to read our award-winning journalism on the go and stay up-to-date with our notifications.
Get the app Get the app
ANDROID iOS
  • Home
  • Common Ground
  • The India Fix
  • Eco India
  • The Latest
  • The Reel
  • Magazine
  • Video
  • Trending
    • Historical romance: In 1906, an Englishwoman is infatuated by the handsome Indian groom of her horse
    • Review: Rekha is the life and soul of Muzaffar’s Ali’s classic ‘Umrao Jaan’
    • Through a reader’s eyes: Bloomsday celebrations in James Joyce’s city, Dublin
    • ‘Map of Memories’: Experimental poems resonate with the poet’s identity as migrant, scholar, thinker
    • Maharashtra withdraws orders to teach Hindi as third language in primary schools
    • What Iranians in India think about the war and Tehran
    • ‘Vanishing World’: Sayaka Murata’s new novel warns readers of a world bereft of love and belonging
    • Andhra Pradesh: Mango farmers battle erratic weather, crop pests
    • Harsh Mander: The plunder and loot by private healthcare in India
    • Fiction: A scheme to unearth the ‘lost’ Saraswati river becomes an act of Hindu nationalist pride
    • In Bengaluru, an ancient play finds new voice in the world’s oldest living dramatic tradition
    • ‘A dry future powered by the sun’: Solar water pumps are draining India’s groundwater reserves
  • Sections
    • Politics
    • Culture
    • India
    • World
    • Film and TV
    • Music
    • Books and Ideas
    • Business and Economy
    • Science and Technology
    • In Pictures
    • Announcements
    • Bookshop
    • The Field
    • Pulse
    • Elections 2024

Roche

  • HC allows Natco Pharma to make Swiss firm Roche’s spinal muscular atrophy drug in public interest

    HC allows Natco Pharma to make Swiss firm Roche’s spinal muscular atrophy drug in public interest

    Scroll Staff
    · Mar 26, 2025 · 01:25 pm
  • Pharmaceutical sector: Why India needs a regulatory pathway for biosimilar drugs

    Pharmaceutical sector: Why India needs a regulatory pathway for biosimilar drugs

    Dinesh Thakur Prashant Reddy T
    · Mar 07, 2024 · 09:00 am
  • Coronavirus: Cipla, Roche launch antibody cocktail in India at Rs 59,750 per dose

    Coronavirus: Cipla, Roche launch antibody cocktail in India at Rs 59,750 per dose

    Scroll Staff
    · May 25, 2021 · 07:48 am
  • Competition Commission of India pulls up Roche for anti-competitive practices

    Competition Commission of India pulls up Roche for anti-competitive practices

    Jyotsna Singh
    · Apr 26, 2017 · 08:30 pm
  • Photos: Why women and men wearing bras ambushed a pharma giant in Durban

    Photos: Why women and men wearing bras ambushed a pharma giant in Durban

    Priyanka Vora
    · Jul 21, 2016 · 09:00 pm